Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Matever

Matever 250 mg film-coated tablets Matever 500 mg film-coated tablets Matever 750 mg film-coated tablets Matever 1000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10–11

HOS-213261 · Präparat HOS-155076

10 disorders am QT prolonged Respiratory, Cough thoracic and mediastinal disorders Gastrointestin Abdominal pain, Pancreatitis al disorders diarrhoea, dyspepsia, vomiting, nausea Hepatobiliary Liver function Hepatic failure, disorders test abnormal hepatitis Skin and Rash Alopecia, Toxic subcutaneous eczema, epidermal tissue pruritus, necrolysis, disorders Stevens- Johnson syndrome, erythema multiforme Musculoskele Muscular Rhabdomyolysi tal and weakness, s and blood connective myalgia creatine tissue phosphokinase disorders increased(3) Renal and Acute kidney urinary injury disorders General Asthenia/fatigue disorders and administratio n site conditions Injury, Injury poisoning and procedural complications (1) See Description of selected adverse reactions. (2) Very rare cases of development of obsessive-compulsive disorders (OCD) in patients with underlying history of OCD or psychiatric disorders have been observed in post-marketing surveillance. (3) Prevalence is significantly higher in Japanese patients when compared to non-Japanese patients.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.